Novel approach to guided drug development utilizes clinical and market insights to identify deficiencies in standards of care and match patients with optimal therapies SHANGHAI--(BUSINESS WIRE)--D3 ...

SHANGHAI, Dec. 9, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a ...

Calcitriol (Bio -D3) is a synthetic vitamin D analog, prescribed for hypocalcemia in patients undergoing chronic renal dialysis.It helps proper absorption and use of calcium and phosphate in the body.

Investment will support development of a differentiated pipeline in oncology Most advanced asset is D3S-001 with potential to be a best-in-class KRAS G12C inhibitor Data on lead asset D3S-001 to be ...

Global biotech headed by seasoned industry veterans secures backing from world-class investor syndicate Novel approach to guided drug development utilizes clinical and market insights to identify ...